Please assess the completion status of the following clinical trial:

Trial Title: Effect of the Motilin Receptor Agonist, Erythromycin, on Hunger and Food Intake; Study of Role of Cholinergic Pathways

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion criteria:~* Female or male subjects aged 18 to 60~* Subject is capable and willing to give informed consent~* Female volunteers of child bearing potential must use oral, injected or implanted hormonal methods of contraception~Exclusion criteria:~* Female volunteer is pregnant or breastfeeding~* Gastrointestinal diseases, major abdominal surgery~* Major psychiatric illnesses~* Volunteers that use drugs affecting the gastrointestinal tract or the central nervous system~* Allergy for macrolide antibiotics~* Allergy for atropine~* Severe heartburn~* Enlarged prostate~* Blockage of urinary tract~* Acute closed-angle glaucoma~* Myasthenia gravies~* Severe heart disease~* Thyrotoxicosis~* Fever~* Liver problems~* High blood pressure or fast heart rate~* Lung disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Erythromycin lactobionate (Type: ACTIVE_COMPARATOR): 40 mg erythromycin lactobionate was administered over a 20 min period in a volume of 100 ml sodium chloride 0.9 %
- Erythromycin lactobionate with atropine (Type: ACTIVE_COMPARATOR): 40 mg erythromycin lactobionate was administered over a 20 min period in a volume of 100 ml sodium chloride 0.9 %; Atropine sulfate was given as an i.v. bolus (15 µg/kg) followed by a continuous infusion of 15 µg/kg/h over 30 min
- Atropine (Type: PLACEBO_COMPARATOR): Atropine sulfate was given as an i.v. bolus (15 µg/kg) followed by a continuous infusion of 15 µg/kg/h over 30 min.~Infusion of saline as a placebo for erythromycin was administered over a 20 min period in a volume of 100 ml sodium chloride 0.9 %
- Placebo (Type: PLACEBO_COMPARATOR): Infusion of saline was administered over a 20 min period in a volume of 100 ml sodium chloride 0.9 %; also placebo for atropine was given as an i.v. bolus of saline followed by a continuous infusion over 30 min

Based on this trial design, predict the completion outcome and termination type (if applicable).